| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |